Clinical trial
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
NCT07728383
Study timeline
Study start (actual)2026-06-17Date precision: day
Registry last updated2026-07-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesity & Overweightunresolved
Interventions
Sponsors & collaborators
Gila Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07728383 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.